Why the Patient Journey Matters Clinical trials depend on participants. Yet for many patients and their families, deciding to participate in a clinical trial is only the beginning of the journey. Getting to appointments, arranging flights and hotels, coordinating transportation, paying expenses upfront, traveling with a caregiver, and navigating reimbursement
Connecting Patients, Sites and Study Teams Across Borders Clinical trials are becoming increasingly global. Patients may travel across cities, states, or even international borders to access specialized treatments and participate in studies. While expanding a trial geographically can help sponsors reach more diverse patient populations, it also introduces another layer
Patient Payments and Reimbursements Clinical trial participation can require a significant investment of time, travel, and personal resources from patients and their caregivers. Even when a study offers an important opportunity to access new treatments or advance medical research, out-of-pocket expenses can create an additional barrier to participation. Travel costs,
World Lung Cancer Remembrance Month: Honoring Lives, Advancing Hope Through Clinical Trials Every August, World Lung Cancer Remembrance Month serves as a time to honor the lives of those affected by lung cancer, support patients and caregivers navigating the disease today, and recognize the ongoing research that continues to change
Navigating the Operational Reality of Oncology Trials: Why Travel & Expense Design Matters to Sponsors Oncology clinical trials are designed around scientific rigor, regulatory precision, and the promise of advancing care. But beneath the protocol design and endpoints sits a quieter determinant of success: whether participants can realistically stay engaged
Sarcoma Awareness Month: Advancing Hope Through Research, Collaboration, and Clinical Trials Every July, Sarcoma Awareness Month brings attention to one of the rarest and most diverse forms of cancer while recognizing the patients, families, clinicians, researchers, and advocates dedicated to improving outcomes. Sarcomas account for approximately 1% of adult cancers
